Intelligence / Healthtech / New Clinical Trials
ClinicalLIVEUpdated 18 Nov 2026
New Clinical Trials
Clinical trials companies registered in the last 30 days, worldwide, with the sponsor, phase and countries.
Sources: ClinicalTrials.gov · Rebuilt weekly · Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase.
Trials
777
in the 30 days to 2026-11-18
Added in 30 days
777
to 18 Nov 2026
Top country
United States
192 · 25% of the list
Phase covered
8
distinct values
Snapshot · 18 Nov 2026
Explore all 777 Growth
By month
777
Signals
What the register says this week, and why it matters if you sell into it.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
- 174 of the listed studies are device, diagnostic or digital-health studies (no drug phase).
- A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
PostedSponsorStudyPhaseStatus
21 Oct 2026Innovent Biologics (Suzhou) Co. Ltd.ChinaIBI3034 Study in Healthy Adults and Patients With Primary IgA NephropathyPhase 1Not Yet Recruiting21 Oct 2026Lee's Pharmaceutical LimitedChinaStudy to Evaluate the Safety, Tolerability, and Pharmacokinetics of Recombinant Anfibatide Injection in Healthy VolunteersPhase 1Not Yet Recruiting21 Oct 2026Vigonvita Life SciencesStudy of the Safety, Tolerability, Pharmacokinetics of VV147 Tablets in Chinese Healthy Participants.Phase 1Not Yet Recruiting20 Oct 2026Dignify TherapeuticsUnited StatesA Single Ascending Dose Study of DTI-117 Given Intramuscularly in Healthy Participants.Phase 1Recruiting20 Oct 2026Eli Lilly and CompanyUnited States, SingaporeA Study of LY4167586 in Participants With Obesity or Overweight With or Without Type 2 DiabetesPhase 1Recruiting20 Oct 2026Eli Lilly and CompanyUnited States, CanadaA Study of LY3873862 in Participants With Sporadic or Familial Amyotrophic Lateral Sclerosis (ALS).Phase 1Not Yet Recruiting20 Oct 2026Hoffmann-La RocheDenmark, United KingdomA Study of RO7821657 in Participants With Solid TumorsPhase 1Recruiting20 Oct 2026Shenzhen Salubris Pharmaceuticals Co., Ltd.ChinaThe First-in-Human Study of GW906 InjectionPhase 1Completed// How AOS uses this